tiprankstipranks
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2

Compare Alnylam Pharma (0HD2) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Alnylam Pharma
$321.74
$42.61B
166.04
47.69%
16 Buy
3 Hold
0 Sell
Strong Buy
Incyte
$96.96
$19.30B
14.98
74.13%
8 Buy
8 Hold
1 Sell
Moderate Buy
Vertex Pharmaceuticals
$436.27
$110.83B
29.32
-8.25%
21 Buy
4 Hold
0 Sell
Strong Buy
Argenx Se
$800.50
$49.10B
14.76
46.40%
17 Buy
2 Hold
0 Sell
Strong Buy
Genmab
$28.28
$17.43B
19.86
56.86%
8 Buy
2 Hold
0 Sell
Strong Buy
BioNTech SE
$91.98
$24.00B
-17.95
2.56%
14 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0HD2
Alnylam Pharma
326.40
92.77
39.71%
INCY
Incyte
96.07
39.20
68.93%
VRTX
Vertex Pharmaceuticals
436.27
-47.95
-9.90%
ARGX
Argenx Se
799.65
218.71
37.65%
GMAB
Genmab
28.25
9.44
50.19%
BNTX
BioNTech SE
95.50
-1.02
-1.06%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts